Explore

Trendline Trendline
Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors to Enhance Financial Strategy

Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors to Enhance Financial Strategy

Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors to Enhance Financial Strategy
Trendline Trendline
Parabilis Medicines Strengthens Board with Appointment of Finance Leader Alan M. Sebulsky

Parabilis Medicines Strengthens Board with Appointment of Finance Leader Alan M. Sebulsky

Parabilis Medicines Strengthens Board with Appointment of Finance Leader Alan M. Sebulsky
Trendline Trendline
Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth

Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth

Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth
Trendline Trendline
Jeff Bezos' Representative Departs Slate Auto Board Amidst Production Preparations

Jeff Bezos' Representative Departs Slate Auto Board Amidst Production Preparations

Jeff Bezos' Representative Departs Slate Auto Board Amidst Production Preparations
Trendline Trendline
AN2 Therapeutics to Engage in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Engage in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Engage in 2026 Stifel Virtual Targeted Oncology Forum
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy
Trendline Trendline
Nona Biosciences Launches Updated Brand Identity to Enhance Biotherapeutic Innovation

Nona Biosciences Launches Updated Brand Identity to Enhance Biotherapeutic Innovation

Nona Biosciences Launches Updated Brand Identity to Enhance Biotherapeutic Innovation
Trendline Trendline
Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting

Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting

Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting
Trendline Trendline
Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast
Trendline Trendline
4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA